motility of the gut depends on the chemicals contained in the lumen, but the stimuli that modify motility and their relationship to enteric neural pathways are unclear. This study examined local inhibitory reflexes activated by various chemical stimulants applied to the mucosa to characterize effective physiological stimuli and the pathways they excite. Segments of the jejunum were dissected to allow access to the circular muscle on one-half of the preparation while leaving the mucosa intact on the circumferentially adjacent half. Chemicals were transiently applied to the mucosa, and responses were recorded intracellularly in nearby circular muscle cells. The amino acids L-phenylalanine, L-alanine, or L-tryptophan (all 1 mM) evoked inhibitory junction potentials (IJPs; latency 150 -300 ms, amplitude 3-8 mV, each n Ͼ 6) that were blocked by TTX and partially blocked by antagonists of P2X receptors and/or a combination of antagonists at 5-HT3 and 5-HT4 receptors. The putative mediators 5-HT (10 M), ATP (1 mM), and CCK-8 (1-10 M) elicited IJPs mediated via 5-HT3, P2X, and CCK-B receptors, respectively. Responses were only partially reduced by the effective antagonists. IJPs evoked by electrically stimulating the mucosa were unaffected by antagonists that reduced chemically evoked responses. Both chemically and electrically evoked IJPs were resistant to nicotinic, NK1, NK3, ␣-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, N-methyl-Daspartate, or CGRP receptor blockade. We conclude that mucosal stimulation by amino acids activates local neural pathways whose pharmacology depends on the nature of the stimulus. Transmitters involved at some synapses in these pathways remain to be identified. 5-HT3 receptors; P2X receptors; cholecystokinin receptors; enteric reflexes THE INTESTINE "senses" the chemical environment within its lumen and alters its motor activity appropriately. When nutrients are present, segmentation is the dominant motor pattern and intestinal transit is slowed, which maximizes nutrient digestion and absorption (61). Segmentation can be evoked in the guinea pig small intestine in vitro by an intraluminal infusion of fatty acids (35) or individual amino acids (33, 34) . This motor pattern is neurally mediated. However, the way that the enteric nervous system (ENS) detects changes in the luminal environment and activates neural circuits to bring about appropriate changes in motor behavior is poorly understood.
across the basolateral membrane in response to chemical stimuli, thereby activating sensory nerve terminals innervating the mucosa (1, 25, 60) . For example, 5-HT is released from EC cells in response to some chemical stimuli (44) , and both fatty acids and amino acids release CCK from the mucosal epithelium (50, 63, 71) . Furthermore, exogenous application of 5-HT or ATP to the mucosa in the guinea pig small intestine excites the terminals of myenteric AH/Dogiel type II cells through activation of 5-HT 3 and P2X receptors, respectively (4, 7) . However, whether such nutrients activate enteric neural pathways has not been determined directly, so it is difficult to identify the physiological significance of mediators that they release from the mucosa. The aims of this study were to identify effective, physiologically relevant, chemical stimuli that can be applied to the mucosa and to characterize the neural pathways they activate.
We applied amino acids that are known to evoke segmentation to the mucosa and recorded responses with intracellular electrodes in nearby circular smooth muscle cells. To determine if endogenous release of mediators from the mucosa was involved, we compared control responses with those recorded in the presence of antagonists against receptors for 5-HT, ATP, and CCK and in the presence of nicardipine.
METHODS
Tissue preparation. Guinea pigs (200 -380 g) of either sex were killed by being stunned and having their carotid arteries severed. This procedure was approved by the University of Melbourne Animal Experimentation Ethics Committee. The abdominal cavity was opened, and segments of the jejunum (5 cm in length) were removed just anal to the duodenal-jejunal junction, flushed clean, and placed in oxygenated (95% O 2-5% CO2) physiological saline solution [composed of (in mM) 118 NaCl, 4.6 KCl, 2.5 CaCl2, 1.2 MgSO4, 1 NaH2PO4, 25 NaHCO3, and 11 D-glucose). Each segment was opened along its mesenteric border and pinned flat in a dissecting dish lined with a Silicone elastomer (Sylgard 184, Dow Corning). The mucosa and submucosa were removed over half the preparation to allow access to the circular muscle (CM) at the junction between the intact and dissected halves. The preparation was then transferred to a recording bath (volume ϳ1-2 ml) that was perfused with warmed physiological saline solution (35°C) at a flow rate of 5 ml/min. The preparation was left to equilibrate for 1-2 h before experiments were commenced. The physiological saline solution contained hyoscine (1 M) to minimize muscle contractions.
Electrophysiology. An Olympus inverted microscope was used to visualize an area of the CM next to the intact mucosa, and CM cells were impaled using glass microelectrodes (100 -200 M⍀ resistance) containing 1 M KCl. Voltage recordings were made using an Axoprobe 1A microelectrode amplifier (Axon Instruments) and acquired to a personal computer using a Powerlab/4SP acquisition system and Chart4 for windows software (ADI instruments, New South Wales, Australia). CM cells with stable membrane potentials between Ϫ45 and Ϫ55 mV were studied.
Chemical stimulation of the mucosa. Solutions of L-phenylalanine, L-alanine, L-tryptophan, and D-aspartate (all 1 mM) as well as 5-HT (10 M), ATP (1 mM), and CCK-8 (1 M) were made up weekly in distilled water (pH neutral). Each agonist was applied to the mucosa by pressure ejection (150-ms duration) within a radius 1-3 mm circumferential and slightly oral to the recording site to maximize the chance of stimulating an inhibitory junction potential (IJP) in the CM (5) . The recording trace was marked at the time of pressure ejection by passing a 1-ms duration hyperpolarizing current pulse through the recording electrode when the pressure ejection was triggered. Each agonist was tested at several locations, and the position, or "hot spot," that consistently elicited the largest-amplitude IJPs was used to test the effects of antagonists. A minimum of three responses was recorded at 5-min intervals before antagonists were added to the perfusing solution. Three responses were recorded with antagonists present before the drugs were washed from the bath (20 -30 min) . Three trials were recorded after the washout period to determine if any effect seen with an antagonist present was reversible. In most cases, a single impalement was held throughout control, antagonist, and washout trials. When impalements were lost, a new impalement was made in the same location on the muscle. Stock solutions of antagonists were initially made up in distilled water and diluted to working concentrations on the day of the experiment.
Drugs used in these experiments included the following: TTX (Alomone Labs, Jerusalem, Israel), ATP, CCK-8, 5-HT, hyoscine, hexamethonium, nicardipine, PPADS, 6,7-dinitro-quinoxaline-2,3- Electrical stimulation of the mucosa. A bipolar stimulating electrode (75-m tungsten wire insulated with 20 m Teflon, Goodfellow, UK) was used to deliver current pulses (2-6 mA, duration 0.5 ms) to the mucosa 3-4 mm circumferential and oral to the recording electrode (Master-8 stimulator, ISO-flex stimulus isolation unit, AMPI). A single electrical pulse was delivered to the mucosa 1 min prior to each agonist application.
Controlling for stimulus spread. To control for the possibility that the chemical stimuli were not acting on the mucosa but on neural structures within the submucosa or myenteric plexus, two further sets of experiments were undertaken. Initial responses to 5-HT, ATP, L-alanine, L-phenylalanine, L-tryptophan, or electrical stimulation (ES) were recorded, and the mucosa and submucosa were then lifted together as a sheet away from the CM to break connections between the mucosa and the underlying layers. The mucosa and submucosa were then replaced in their original position and pinned as before, and stimuli were reapplied in the same or similar locations. The dissection took no longer than 5 min. A previous study (46) has indicated that this procedure does not interfere with the integrity of the underlying myenteric plexus or the viability of the mucosa.
In the second series, the mucosa and submucosa were completely removed after control responses were recorded, and chemical and electrical stimuli were reapplied directly onto the CM in the same or similar locations.
Analysis and statistics. Latencies and amplitudes of IJPs are presented as means Ϯ SE unless otherwise stated. Statistical comparisons were made using paired t-tests and repeated-measures ANOVA where appropriate. P values of Ͻ0.05 were taken to indicate statistical significance.
RESULTS
Experiments were performed in the presence of hyoscine (1 M) to reduce contraction of the muscle during intracellular recordings, and this allowed stable CM cell impalements to be achieved. CM cells had an average resting membrane potential of Ϫ50 mV, and baseline CM activity consisted of spontaneous IJPs and occasional depolarizations that could trigger action potentials.
Responses evoked by chemical stimuli consisted of an IJP, often followed by a slow depolarization. Equivalent volumes of distilled water or physiological saline solution were tested to control for the vehicle and for mechanical distortion caused by the chemical spritzes. Responses to distilled water or saline were rare, inconsistent, and small (Ͻ2 mV).
Responses to amino acids, 5-HT, ATP, or CCK were only observed from a few specific locations, or hot spots, on the mucosa. Furthermore, the exact nature of chemically evoked responses depended in part on the location of the hot spot. Agonists were more likely to evoke an IJP alone when the hot spot was oral to the impalement, and a depolarization was more likely to be observed following an IJP when the hot spot was directly circumferential to the recording site. IJPs were not seen when agonists were applied anal to the recording electrode.
Responses to mucosal application of amino acids. Application of L-phenylalanine, L-alanine, or L-tryptophan (all 1 mM) to hot spots on the mucosa elicited time-locked IJPs in nearby CM cells with latencies between 150 and 300 ms (Fig. 1, A-C Since these responses were relatively small and hot spots were difficult to locate, we could not systematically test the effects of lower concentrations of amino acids. However, higher concentrations of L-alanine (30 mM, n ϭ 4) and L-phenylalanine (30 mM, n ϭ 4) did not evoke larger IJPs. Furthermore, application of L-alanine, L-tryptophan, and L-phenylalanine together at the same total concentration as used individually (1 mM) or at a higher total concentration (10 mM) did not evoke larger amplitude responses. Responses to the amino acids were neurally mediated, because they were abolished by TTX (1 M) (L-alanine, L-phenylalanine, and L-tryptophan, each 1 mM, n ϭ 4, not illustrated).
D-Aspartate (1 mM) was much less effective than the other amino acids at evoking IJPs. IJPs were recorded in four of six preparations, their amplitudes ranged from 2.0 to 5.3 mV (mean 3.8 Ϯ 1.0 mV, not illustrated), and they were difficult to reproduce.
In 7 of 12 trials with L-phenylalanine, 7 of 12 trials with L-alanine, and 3 of 6 trials with L-tryptophan, IJPs were followed by slow depolarizations. However, their amplitudes and durations varied greatly both within and between experiments, which made them difficult to quantify or characterize pharmacologically. D-Aspartate never elicited a slow depolarization.
Pharmacology of responses evoked by amino acids. Amplitudes of IJPs evoked by L-phenylalanine, L-alanine, or L-tryptophan were significantly reduced by 23% (P Ͻ 0.05, n ϭ 8), 41% (P Ͻ 0.05, n ϭ 7), and 46% (P Ͻ 0.05, n ϭ 5), respectively, by the P2X receptor antagonist PPADS (10 M) or by 21% (P Ͻ 0.05, n ϭ 6), 27% (P Ͻ 0.025, n ϭ 6), and 65% (P Ͻ 0.025, n ϭ 5) by tropisetron (10 M), which blocks both 5-HT 3 and 5-HT 4 receptors at this concentration (21, 37, 43) (Fig. 1, A-C, right) .
Because the initial pharmacological profile of the responses to each of the three effective amino acids was the same, further characterization focused on L-alanine as a representative of all three. Some experiments were undertaken with L-phenylalanine to test conclusions from L-alanine or to extend the observation set when responses were unaffected by specific antagonists.
The combination of specific 5-HT 3 and 5-HT 4 receptor antagonists, ondansetron (3 M) and SB-204070 (100 nM), respectively, significantly depressed L-alanine-evoked IJPs by 54% (P Ͻ 0.0005, n ϭ 6, Fig. 1B , right; L-phenylalanine and L-tryptophan were not tested). Ondansetron and SB-204070 were ineffective against L-alanine-or L-phenylalanine-evoked IJPs when applied individually (n ϭ 4 in each case).
When combined, PPADS (10 M) and tropisetron (10 M) reduced IJPs evoked by L-phenylalanine and L-alanine by 30 -40% more than when either antagonist was added alone (P Ͻ 0.05, n ϭ 4 in each case, Fig. 1 , A and B, right). However, this further reduction was not statistically significant when compared with the reductions seen when either antagonist was added alone.
PPADS at 30 M did not reduce IJPs evoked by L-phenylalanine or L-alanine significantly more than 10 M PPADS (Fig. 1 , A and B, right; n ϭ 6 in each case). L-Alanine-evoked responses were unaffected by the nicotinic acetylcholine receptor antagonist hexamethonium (200 M, n ϭ 4), the CGRP antagonist human CGRP 8-37 (1 M, n ϭ 6), the NK 1 tachykinin receptor antagonist SR-140333 (100 nM, n ϭ 4), or combined application of the CCK-A and -B antagonists devazepide and L-365260 (each 100 nM, n ϭ 4). Due to the large number of agonist and antagonist combinations tested, only data for effective antagonists are presented graphically. For complete data on the effects of the antagonists tested, see Supplementary Table 1 ; the effects of antagonists on chemically and electrically evoked IJPs are available as on-line supplementary material. 1 Due to the variability in amplitude and duration of the depolarizations evoked by the amino acids within the same preparation, we could not determine if PPADS (30 M) or tropisetron (10 M) affected these responses. However, in one set of experiments where consistent depolarizations were evoked by L-alanine, we found that combined application of the CCK-A and -B antagonists devazepide and L-365260 (100 nM, each n ϭ 4) had no effect.
Responses to mucosal application of 5-HT, ATP, and CCK. IJPs evoked by mucosal application of 5-HT, ATP, or CCK had larger amplitudes, but similar latencies, to amino acidinduced responses. The average amplitudes were 5.5 Ϯ 0.7 mV (range 3.6 -9.0 mV, n ϭ 6), 7.7 Ϯ 1.8 mV (range 3.8 -21.3 mV, n ϭ 8), and 5.4 Ϯ 0.3 mV (range 3.0 -8.4 mV, n ϭ 8), respectively (Fig. 2, A-C, left) . These did not differ significantly from each other. Responses to 5-HT, ATP, and CCK were more robust than amino acid-induced IJPs, and it was easier to find a hot spot on the mucosa where application of these compounds consistently evoked IJPs. Responses to 5-HT, ATP, and CCK were abolished by TTX (1 M, each n ϭ 4).
Slow depolarizations, which sometimes triggered action potentials, were seen in 7 of 12 trials with 5-HT, 8 of 12 trials with ATP, and 11 of 12 trials with CCK (Fig. 2 , A-C, right) and were abolished by TTX. These responses were more reproducible than depolarizations evoked by amino acids. 5-HT evoked shorter depolarizations lasting 5-15 s with amplitudes ranging from 5 to 15 mV. ATP and CCK evoked longer-duration depolarizations lasting 15-30 and 30 -60 s, respectively, with amplitudes ranging from 5 to 20 mV.
Pharmacology of responses evoked by 5-HT, ATP, and CCK. The amplitudes of 5-HT-evoked IJPs were reduced by ondansetron (3 M) or tropisetron (10 M) by 73% (P Ͻ 0.0001, n ϭ 6) and 64% (P Ͻ 0.0001, n ϭ 6), respectively (Fig. 3, A-C) . PPADS (10 M) significantly reduced 5-HTevoked IJPs but only by 20 -30% (P Ͻ 0.01, n ϭ 6; Fig. 3 , A and D). PPADS (30 M) had no greater effect (Fig. 3A) . 5-HT-evoked IJPs were resistant to hexamethonium, the tachykinin receptor antagonists SR-140333 (NK 1 ) and SR-142801 (NK 3 ), the specific 5-HT 4 receptor antagonists SB-204070 and SB-207266, the 5-HT 7 receptor antagonist SB-269970, MRS-2179 (P2Y 1 ), devazepide (CCK-A), and L-365260 (CCK-B) and combined application of DNQX (AMPA) and 2-APV (NMDA) (see Supplementary Table 1 for details). All antagonists were tested at concentrations known to be effective in the ENS.
Ondansetron and tropisetron blocked slow depolarizations evoked by 5-HT (both n ϭ 6), but neither PPADS (10 and 30 M, each n ϭ 6) nor MRS-2179 (10 M, n ϭ 6) affected these responses.
ATP-evoked IJPs were sensitive to PPADS at both 10 M (reduced by 36%, P Ͻ 0.01, n ϭ 8) and 30 M (reduced by 46%, P Ͻ 0.0001, n ϭ 6), but neither concentration was significantly more effective than the other (Fig. 4) . In contrast, 30 M, but not 10 M, PPADS blocked depolarizations evoked by ATP (n ϭ 4, Fig. 4C ). The P2Y 1 receptor antagonist MRS-2179 (10 M) did not affect IJPs (n ϭ 6) and only reduced the depolarization on two of five occasions. Hexamethonium, ondansetron, and tropisetron all had no effect on ATP-evoked responses (see Supplementary Table 1) .
CCK-evoked IJPs and slow depolarizations were affected differentially by the specific CCK-A and -B receptor antagonists devazepide and L-365260, respectively (each 100 nM). IJPs were significantly reduced by 28% by blockade of CCK-B receptors (P Ͻ 0.05, n ϭ 8) but were unaffected by devazepide (P Ͼ 0.1, n ϭ 8; Fig. 5, A-C) . In contrast, devazepide reduced the depolarization seen following the IJP (n ϭ 6), whereas L-365260 left it unaltered (n ϭ 6; Fig. 5, D and E) . Together, the CCK-A and -B antagonists had no additional effect on either part of the response.
Blockade of 5-HT 3 and 5-HT 4 receptors together, with either tropisetron (10 M) or a combination of ondansetron (3 M) and SB-204070 (100 nM), significantly reduced IJPs evoked by CCK by 46% (P Ͻ 0.005, n ϭ 6) and 43% (P Ͻ 0.01, n ϭ 6), respectively, but blockade of 5-HT 3 or 5-HT 4 (with SB-204070) receptors separately had no effect (Fig. 5A) . PPADS (10 M) had no effect. Other antagonists that did not affect CCK-evoked IJPs included hexamethonium, SB-207266, and human CGRP 8-37 (Supplementary Table 1 Electrically evoked responses. ES of mucosal villi evoked IJPs that were sometimes followed by slow depolarizations (Fig. 2D) . IJPs evoked by ES were larger than those elicited in the same cells by chemical stimuli (5-HT, 33% of ES; ATP, 55% of ES; and CCK, 40% of ES) and were abolished by TTX. When recorded, slow depolarizations evoked by a single electrical pulse to the mucosa had durations ranging from 2 to 5 s and amplitudes up to 10 mV. The electrically stimulated IJPs had significantly shorter latencies than chemically evoked IJPs (ES: 82 Ϯ 1 ms and chemical stimulation: 183 Ϯ 2 ms, P Ͻ 0.0001, n ϭ 10; Fig. 2D ) and were unaffected by antagonists that reduced chemically stimulated responses (see Supplementary Table 1 for details). Hexamethonium, ondansetron, tropisetron, SB-204070, SB-207266, PPADS, a combination of DNQX and 2-APV, human CGRP 8-37, the NK 1 or NK 3 tachykinin antagonists SR-140333 and SR-142801, and combined application of devazepide and L-365260 were all ineffective against electrically stimulated IJPs or depolarizations ( Table 1 ). The P2Y 1 receptor antagonist MRS-2179 (10 M) significantly reduced electrically stimulated IJPs, but only by 10 -15% (ES: 11.9 Ϯ 2.0 mV and MRS-2179: 10.5 Ϯ 1.8 mV, P Ͻ 0.0025, n ϭ 6).
Controls for stimulus spread. When responses were seen prior to dissection, chemical or electrical stimuli did not evoke . L-365260 had no effect, whereas devazepide greatly reduced the slow depolarization. *Significance at P Ͻ 0.05 compared with control.
IJPs after the mucosa and submucosa were lifted away from the CM and then replaced (5-HT and ATP, each n ϭ 4; L-alanine, L-phenylalanine, and L-tryptophan, each n ϭ 6; and ES: n ϭ 8). Thus, severing neural connections between the submucosa and myenteric plexus abolished responses to chemical stimuli and ES.
Similarly, IJPs were not recorded when L-alanine, L-phenylalanine, or L-tryptophan (1 mM) was applied directly onto the CM (each n ϭ 6). In two of four preparations, application of ATP (1 mM) to the CM evoked small-amplitude, long-duration hyperpolarizations that were TTX insensitive. In one of four preparations, 5-HT (10 M) applied to the CM evoked a similar hyperpolarization that was also unaffected by TTX. The latencies of these responses were much shorter (50 -100 ms) than the latencies seen with chemically evoked responses through the mucosa. Neither 5-HT nor ATP produced depolarizations in the muscle when they were applied directly. ES of the CM evoked large-amplitude IJPs that were blocked by TTX (n ϭ 8) and had similar latencies to IJPs evoked by ES of the mucosa (80 -100 ms).
DISCUSSION
This study is the first demonstration that physiological levels of amino acids can act at the mucosa to excite local enteric neural circuits. L-Phenylalanine, L-alanine, and L-tryptophan each appear to release both ATP and 5-HT, which act via P2X and a combination of 5-HT 3 and 5-HT 4 receptors, respectively. However, while ATP, 5-HT, and CCK-8 all activate responses that appear identical to each other and to those evoked by the amino acids in their output to the CM, the neural pathways excited are pharmacologically distinct at the level of their activation. The results also indicate that there is a synapse in these neural pathways whose transmitter remains to be identified. It is unlikely to be acetylcholine acting at nicotinic or muscarinic receptors, ATP, CGRP, a tachykinin receptor, or glutamate acting at either AMPA or NMDA receptors.
Activation of local reflexes by physiological stimuli. Although the motility of the upper small intestine is regulated in part by the nutrient content of the lumen (61), which nutrients stimulate enteric pathways have not previously been determined. Various chemical stimulants applied to the mucosa excite terminals of myenteric AH/Dogiel type II neurons (4, 6, 7) . However, the stimulants used in earlier studies are either not normally found in the jejunum (acid and alkaline pH, neutral acetate) or are mediators potentially released from the mucosa (5-HT and ATP). Only acid pH has previously been reported to excite enteric neural circuits, and these were the longitudinally running ascending excitatory and descending inhibitory pathways (64) . The finding that some amino acids excite local inhibitory pathways when applied to the mucosa represents an initial step in understanding how nutrients regulate motility.
Several observations indicate that the mucosa and its connections to the myenteric plexus are essential for the initiation of IJPs evoked by chemical and electrical stimuli applied to the mucosa. Disrupting these pathways eliminated all responses to mucosal stimulation whether chemical or electrical. In addition, no responses were evoked when amino acids were applied directly to the CM, indicating that the mucosa is essential for activation of local neural activity by amino acids. Furthermore, it is unlikely that mediators released from the mucosa by amino acids would diffuse to the myenteric plexus due to the actions of ectonucleotidases and monoamine oxidase on ATP and 5-HT, respectively. Thus, the amino acids and/or mediators applied in the present study probably act within the mucosal layer.
The occasional hyperpolarizations seen when ATP or 5-HT were applied directly to the CM were TTX insensitive and differed in latency, shape, amplitude, and duration from IJPs evoked by their application to the intact mucosa. They probably resulted from direct activation of P2Y receptors or 5-HT 7 receptors on the muscle, respectively, as both receptors are expressed in and mediate relaxation of guinea pig CM (8, 18, 22, 68) . ES of the CM evoked TTX-sensitive IJPs, consistent with direct activation of nerve terminals in the muscle. However, as ES of the mucosa did not evoke IJPs after the mucosa had been detached and replaced on the CM, current spread is unlikely to account for IJPs evoked by stimuli applied to the intact mucosa.
The stereotyped responses to amino acids, putative mediators, and ES of mucosal villi suggest that they all excite the same neural pathway. This must include neurons that are excited by amino acids, 5-HT, ATP, and CCK applied to the mucosa and inhibitory motor neurons that produce IJPs in the CM (Fig. 6 ). There is abundant evidence as to the identity of the latter (for reviews, see Refs. 11 and 14) . The former are very probably AH/Dogiel type II neurons. There is substantial evidence that myenteric AH/Dogiel type II neurons act as "sensory" neurons under some conditions, responding with stimulus-locked bursts of action potentials to transient chemical stimuli, including 5-HT (7) and ATP (4), applied to the mucosa (for reviews, see Refs. 12, 16, 26, 27, and 29) . Toward the end of a burst, action potentials are sometimes truncated due to reduced somatic excitability arising from the neuron's characteristic afterhyperpolarizing potentials. The neurons that respond to chemical stimulation of the mucosa and the neural pathways mediating amino acid-evoked IJPs each have similar receptive fields within the mucosa. Indeed, we have preliminary results indicating that amino acids applied to the mucosa in the same way as the present study evoke short-latency, stimulus-locked trains of action potentials in AH/Dogiel type II neurons and fast excitatory synaptic potentials in S/uniaxonal neurons (see the on-line Supplementary Figure) . Furthermore, myenteric AH/Dogiel type II neurons form excitatory synapses with virtually all other myenteric neurons (47, 56) , including inhibitory motor neurons. Thus, the simplest explanation for the data is that IJPs evoked by amino acids are produced by a monosynaptic neural pathway (Fig. 6) sharing many characteristics with simple reflex pathways seen elsewhere in the nervous system. However, AH/Dogiel type II neurons are organised into recurrent excitatory circuits (12, 26) , and modelling studies (65, 66) have suggested that they act as "interneurons" when prolonged, distributed stimuli are applied to the intestinal wall. This is discussed below in relation to the long-duration depolarizations seen in the present study.
The terminals of AH/Dogiel type II neurons are probably not directly excited by amino acids applied to the mucosa, because they do not penetrate the epithelium and do not contact luminal contents. Mucosal EE cells are ideally positioned to detect changes in luminal chemistry and release their contents via their basolateral membranes in response to nutrients in the lumen (1, 25, 60) . It is well established that the chemicals released activate nerve terminals of intrinsic and extrinsic neurons lying close by in the lamina propria (4, 7, 9, 10, 53) . Some EE cells express surface receptors that bind particular nutrients (23, 32, 41) , but it is unknown if they bind amino acids. There is little information about the physiological concentrations of mucosally released mediators in the interstitial space between the epithelium and nerve endings innervating the mucosa, and none about concentrations produced by amino acid stimulation of the mucosa. Circulating levels provide no clues, as a result of the diluting effect of the blood. However, Bertrand (2, 3) measured local release of 5-HT evoked by mechanical stimuli and contraction and reported that these stimuli produced local concentrations of 5-HT in the range of 10 M, which is the concentration we applied to the mucosa in the present study. Similar data are not available for ATP or CCK.
The responses to amino acids and to ATP, 5-HT, and CCK-8 probably result from release of mediators from EE cells. All chemically evoked responses had long latencies, consistent with a transduction process, as opposed to the short latencies seen with ES of mucosal nerve terminals. Furthermore, amino acid-evoked IJPs were depressed by PPADS and/or 5-HT 3 and 5-HT 4 antagonists, indicating the involvement of endogenous ATP and 5-HT. Neither PPADS nor the 5-HT antagonists affected electrically evoked IJPs, suggesting that they were not acting at synapses within the pathway but on AH/Dogiel type II nerve terminals (Fig. 6) . Finally, responses evoked by 5-HT were depressed by PPADS and responses to CCK-8 were depressed by 5-HT antagonists. It is known that ATP, 5-HT, and CCK excite the cell bodies of myenteric AH/Dogiel type II neurons (42, 62, 70) and ATP and 5-HT excite their mucosal terminals (4, 7). Thus, these observations, taken together, suggest that lumenal 5-HT, ATP, and CCK may release other mediators as well as act directly on terminals of AH/Dogiel type II neurons.
The release of 5-HT from EC cells largely depends on L-type Ca 2ϩ channels, but is not completely abolished by low-Ca 2ϩ solutions or L-type Ca 2ϩ channel blockers (44, 58) . Thus, it was surprising that IJPs evoked by amino acids in the presence of the L-type Ca 2ϩ channel antagonist nicardipine were indistinguishable from control IJPs. However, direct measurement of 5-HT release from EC cells in the guinea pig ileum during motor activity indicates that it results from mucosal deformation produced by smooth muscle contraction (3). Thus, inhibition of 5-HT release by L-type Ca 2ϩ channel blockade might be secondary to a block of contraction rather than a direct effect on release itself. There may be multiple mechanisms that release 5-HT from the mucosa, not all of which depend on L-type Ca 2ϩ channels. It appears that the proportion of 5-HT release occurring via the activation of L-type Ca 2ϩ channels is small in our preparation. This issue can only be resolved by a high-resolution analysis (2, 3) of 5-HT release evoked by amino acids from the intact mucosal epithelium.
The mechanisms underlying mucosal ATP release are largely unknown. Our results suggest that this may be independent of L-type Ca 2ϩ channels. Subepithelial fibroblasts, which form networks directly under the intestinal epithelium, can act as mechanosensors, responding to mechanical stimuli by releasing ATP via the release of Ca 2ϩ from intracellular stores (28) . Thus, there may be several types of mucosal cells that release mediators via various different mechanisms.
Combined blockade of P2 receptors and 5-HT 3 and 5-HT 4 receptors did not abolish the inhibitory responses, suggesting that another mediator is involved. This is unlikely to be CCK, because CCK-A and CCK-B antagonists did not affect IJPs evoked by amino acids. This was surprising since L-phenylalanine and L-tryptophan release CCK from the mucosa (50, 71) . However, the concentrations used here were lower (1 mM) than those used in previous studies (up to 50 mM) of activation of extrinsic afferents (51), intestinal motility (13, 17) , and CCK release (50, 71) . Thus, the intestine may be exposed to a range of concentrations of amino acids that activate local reflexes during the digestive process.
Receptors exciting the inhibitory pathways responding to amino acids. The PPADS-sensitive component of the inhibitory response to amino acids was probably mediated by P2X receptors on terminals of AH/Dogiel type II neurons. The concentration of PPADS used (10 M) blocks most P2X receptors (48) , and ATP is known to excite the mucosal terminals of chemosensitive myenteric AH/Dogiel type II neu- rons via these receptors (4). Furthermore, ATP itself activated inhibitory reflexes in the present study that were depressed by 10 M PPADS. PPADS is ineffective against most P2Y receptors (59). However, while it blocks P2Y 1 receptors, the more specific P2Y 1 antagonist MRS-2179 had only a small effect on these IJPs, perhaps via muscle P2Y 1 receptors that mediate IJPs (69) . P2Y receptors play a role in secretory reflexes evoked by mucosal stimulation (20) , so definitive conclusions about roles of P2Y receptors will require studies with more specific antagonists.
The effects of 5-HT antagonists are complex. Combined blockade of 5-HT 3 and 5-HT 4 receptors reduced amino acidand CCK-8-evoked IJPs but not electrically evoked IJPs, consistent with a role for 5-HT in activation of, but not within, the pathway. Blockade of 5-HT 3 or 5-HT 4 receptors individually had no effect. Studies (40, 52) of colonic motility yielded similar results, as both 5-HT 3 and 5-HT 4 receptors must be blocked to abolish transit and blockade of either receptor on its own is ineffective. In the present study, inhibitory responses evoked by 5-HT were mediated exclusively through 5-HT 3 receptors, consistent with the finding that 5-HT applied in this way excites terminals of myenteric AH/Dogiel type II neurons via 5-HT 3 receptors (7). The differences in pharmacology of the amino acid-and 5-HT-evoked responses might be due to differing concentrations of 5-HT reaching the receptors in the two protocols. Exogenous 5-HT was applied at 10 M, which activates low-affinity 5-HT 3 Alternatively, 5-HT 4 receptors may act to enhance transmission at an early point in the inhibitory pathway, as they are known to enhance transmitter release at enteric synapses (54, 55, 67) . ATP and 5-HT act directly on common nerve terminals of AH/Dogiel type II neurons (4). Thus, activation of 5-HT 4 receptors might compensate for any loss of a 5-HT 3 mediated component of the response, when the latter is blocked. However, the location(s) of 5-HT 4 receptors and the way they act individually or together with 5-HT 3 receptors to initiate reflexes are issues that remain to be resolved.
Transmission to inhibitory motor neurons. Although the responses seen in this study clearly involve activation of enteric inhibitory motor neurons, the only conclusions that can be drawn from this study about transmission to these neurons are negative. All inhibitory motor neurons receive cholinergic input via nicotinic receptors (39, 48) , express P2X receptors (19) , and are excited via P2X receptors in descending inhibitory reflexes (8) , but IJPs evoked by mucosal stimulation were unaffected by blockade of either receptor. Similarly, antagonists against other putative transmitters previously implicated in intestinal motor pathways, tachykinins (36, 38) , CGRP (24, 30) , and glutamate (45, 49), were ineffective against transmission in this short neural pathway. Previous studies (8, 39) of descending inhibitory pathways concluded that transmission from anally projecting AH/Dogiel type II neurons to inhibitory motor neurons was not due to nicotinic, purine, tachykinin, or glutamate receptors, underlining the question of the identity of this transmitter and/or its receptors.
Local excitatory reflexes. The amino acids also initiated slow depolarizations that triggered action potentials in some preparations. These were also evoked by ATP, 5-HT, and CCK-8 as well as by ES of the mucosa. The depolarizations were less robust than the IJPs and were more common when the stimulus was directly circumferential to the recording site. The bias toward more robust IJPs slightly anal to a stimulus may reflect the anal projection of even the shortest inhibitory motor neurons (15) . By contrast, excitatory motor neurons project directly to the CM or, more commonly, orally (15) .
The properties of the slow depolarizations suggest that our stimuli activate motor programs more complex than a monosynaptic pathway. The depolarizations lasted much longer than the excitatory junction potentials evoked in the CM by ES, which indicates that chemical stimuli excite prolonged activity in one or more elements of the enteric neural circuitry. ES and mucosal application of ATP and 5-HT all excite long-lasting synaptic activity in myenteric AH/Dogiel type II neurons and S neurons, and this includes both slow excitatory postsynaptic potentials (EPSPs) and long trains of fast EPSPs. The fast EPSPs apparently result from circuit activity sustained by slow EPSPs and are compatible with the time courses of the slow depolarizations, but not those of IJPs, evoked by chemical stimuli. This suggests that amino acids and the mediators they release excite two pathways: the enteric equivalent of a monosynaptic reflex and another involving partial activation of an extensive and potentially self-sustaining motor program. Due to the localized and transient stimuli used in our study, only a component of this motor program may have been excited. This contrasts with the physiological situation in which a stimulus is sustained over a large area of the mucosa and excites a complex motor program. For example, segmentation induced by an intralumenal infusion of amino acids into an intestinal segment involves episodic, coordinated activation of excitatory motor neurons and an inhibitory surround, punctuated by low levels of activity in inhibitory motor neurons (33) . The motor program circuit probably includes AH/Dogiel type II neurons acting as "interneurons" in addition to a sensory role detecting the amino acids.
That mucosal mediators excite two distinct pathways is supported by the finding that the excitatory and inhibitory pathways activated by mucosally applied CCK-8 or ATP were pharmacologically distinct. CCK-8-evoked slow depolarizations were reduced by devazepide, but IJPs evoked by CCK-8 were depressed by L-365260. Thus, CCK-8 stimulates two pathways: one pathway activating inhibitory motor neurons and the other pathway acting via excitatory motor neurons. Similarly, 10 M PPADS abolished IJPs evoked by ATP but was ineffective on slow depolarizations evoked by this stimulus. A higher concentration of PPADS (30 M) did block the slow depolarizations but had no greater effect on the IJP. By contrast, slow depolarizations evoked by 5-HT applied to the mucosa were abolished by 5-HT 3 antagonists. Thus, if there are separate pathways activating local inhibition and excitation, 5-HT 3 receptors are involved in both.
The inconsistency of slow depolarizations evoked by amino acids meant that we did not test roles for either ATP or 5-HT. However, CCK was unlikely to be involved, because a combination of CCK-A and -B antagonists did not affect slow depolarizations evoked by L-alanine.
Physiological significance. Amino acids are essential for nutrition. The finding that some amino acids activate local inhibitory, and often excitatory, neural circuits is a starting point for understanding the mechanisms by which nutrients modulate intestinal motor patterns to facilitate absorption. The study of local circuits excited by amino acids is an ideal method by which we can investigate the activation by amino acids of complex motor pattern generators responsible for segmentation (33) and local propulsion.
